Schematic representation of treatment schedule with Cisplatin.

<p>In order to determine the impact of administering Cisplatin (2.5 mg/Kg) on EAC tumors growth and blood parameters, the in vivo study was conducted as detailed before. Beginning from day 28, the control non-hyperglycaemic and experimental hyperglycaemic mice were administered with Cisplatin...

Full description

Saved in:

Bibliographic Details
Main Author:	Vidya G. Bettada (22208808) (author)
Other Authors:	Chaithanya G. Basavaraju (15325387) (author), Shalini H. Doreswamy (22208811) (author), SubbaRao V. Tulimilli (22208814) (author), Rimshia Naaz (22208817) (author), Siva Dallavalasa (15325384) (author), Paramahans V. Salimath (12884512) (author), Anjali Devi S. Bettadapura (22208820) (author), Asha Srinivasan (2888567) (author), Rajalakshmi Ramashetty (22208823) (author), Suma M. Natraj (22208826) (author), SubbaRao V. Madhunapantula (2401042) (author)
Published:	2025
Subjects:	Biochemistry Medicine Cell Biology Pharmacology Developmental Biology Cancer Hematology Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified time response curves observe minor changes data also showed 62 &# 181 25 &# 181 125 &# 181 better tumor inhibition vitamin d3 retarded vitamin d3 reduces increased cleaved caspase combined administration consisting tumor growth much different cancer cells cancer cells exposed eac tumors growth vitamin d3 treatment vitamin d3 eac tumors tumor growth cancer cells proliferating cells cancer effects cancer agent vitro </ survivin proteins potent anti effectively compared dependent decrease combination reduced cell proliferation
Tags:	Add Tag No Tags, Be the first to tag this record!

Schematic representation of treatment schedule with Cisplatin.

Similar Items